��ѻ��ý

Almost a year since Roe v. Wade was overturned, escalating efforts to restrict abortion access pose threats to women, physicians, and health equity.

In analysis of more than 16,000 patients, the biggest declines for both heroin and fentanyl were seen in first 10 weeks of treatment.

Millions of people who want to quit smoking need the FDA to deliver on new treatments.

Two very different threats surged to prominence in the 1980s, remaking public health priorities—and the Bloomberg School.

The ruling is another attempt to interfere with the delivery of evidence-based healthcare and control pregnant people’s bodies.

New tools reveal how differences in individual cells within bacterial communities help them survive—and suggest targets for overcoming drug resistance.

Narcan, the naloxone nasal spray used to reverse opioid overdose, was just FDA-approved for over-the-counter sale—a major victory for harm reduction advocates and public health. 

Insulin manufacturer Eli Lilly follows the government’s lead with a $35 price cap. Will manufacturers follow suit?

Thanks to a loophole in the FDA’s drug advertising regulations, some companies are marketing misleading and unproven treatments unchecked—and putting vulnerable populations seeking cures at risk.

Spanning 7 countries, a major piece of global maternal health research found that a low-cost, widely available generic antibiotic can prevent life-threatening sepsis during childbirth in women delivering babies in low- and middle-income countries.  

Analysis found that more than two-thirds of top-selling prescription drugs in U.S.—one of two countries that allows direct marketing to consumers—were rated as having low added benefit compared to other drugs in 2020.

Court documents, including emails, reveal Insys Therapeutics promoted fentanyl-spray cancer painkiller for off-label uses

UCSF-Johns Hopkins Archive’s latest release of records illustrates pharmacies’ repeated failure to heed warning signs and safety guidelines.

Opioid industry documents illuminate the cynical strategies that led to thousands of deaths. Can an archive turn the tragic past into a better future?

For nearly 20 years, the Medicare program has been at the mercy of the private sector. But the Inflation Reduction Act has the potential to save Americans billions of dollars in drug costs.